glp-1 probiotic GLP including Clostridium butyricum Codeage Unveils GLP-1 Probiotic+ Supplement
Description
More than two in five adults in the U.S
Gastrointestinal symptoms: nausea (20%), diarrhea (15%), vomiting (11%), constipation (6%), dyspepsia (6%), abdominal pain (5%), eructation (4%), gastroesophageal reflux disease (3%), abdominal distension (2%) and flatulence (2%)
"Evaluation of the long-term safety, efficacy and cost- effectiveness of GLP-1RAs in adolescents and young adults is needed," her team wrote
Combined global sales of GLP-1 RAs exceeded tens of billions in 2025, fueling massive profitability for the developers
P = 0.54
An overview of once-weekly glucagon-like peptide-1 receptor agonistsavailable efficacy and safety data and perspectives for the future
